← Back
$IOVA All transactions

IOVANCE BIOTHERAPEUTICS, INC.

A

$ Value

$0

Shares

235,000

Price

$0

Filed

Mar 11

Insider

Name

Vogt Frederick G

Title

Interim CEO & General Counsel

CIK

0001719678

Roles

Director Officer

Transaction Details

Transaction Date

2026-03-09

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

235,000

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. | Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant.

Filing Info

Accession No.

0001104659-26-026457

Form Type

4

Issuer CIK

0001425205

Vogt Frederick G's History

Date Ticker Type Value
2026-03-09 IOVA A $0
2026-03-05 IOVA M $0
2026-03-05 IOVA F $123K
2026-03-05 IOVA M $0
2026-03-02 IOVA M $0
2026-03-02 IOVA F $86K
2026-03-02 IOVA M $0
2026-03-02 IOVA M $0
2025-12-02 IOVA M $0
2025-12-02 IOVA F $9K

Other Insiders at IOVA (90d)

Insider Bought Sold Last
BILINSKY IGOR
Chief Operating Officer
2026-03-09
Vogt Frederick G
Interim CEO & General Counsel
2026-03-05
GRAF FINCKENSTEIN FRIEDRICH
Chief Medical Officer
2026-03-09
Roche Corleen M.
Chief Financial Officer
2026-03-09
Puri Raj K.
Chief Regulatory Officer
2026-03-09
Kirby Daniel Gordon
Chief Commercial Officer
2026-03-09